Overview
US hemodialysis products maker's Q1 revenue fell 8% yr/yr due to lower customer volume
Gross margin for Q1 rose to 17% from 16% a year earlier
Company announced operational changes expected to add over $3 mln in annualized gross profit
Outlook
Rockwell Medical sees 2026 net sales between $70 mln and $75 mln
Company expects 2026 gross margin of 18% to 22%
Rockwell Medical forecasts 2026 adjusted EBITDA of $1 mln to $2 mln and positive operating cash flow
Result Drivers
CUSTOMER VOLUME - Co said Q1 sales decline was driven by reduced purchase volume from one customer
OPERATIONAL CHANGES - Co announced operational changes expected to generate over $3 mln in additional gross profit on an annualized basis
EFFICIENCY INITIATIVES - Co said ongoing streamlining and enhancements to operational efficiencies and distribution footprint are expected to generate over $2 mln in annualized savings
Company press release: ID:nBw2gJCXba
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
$17.30 mln
$17.95 mln (2 Analysts)
Q1 Adjusted EPS
-$0.01
-$0.03 (2 Analysts)
Q1 EPS
-$0.04
Q1 Net Income
-$1.60 mln
Q1 Gross Profit
$2.90 mln
Q1 Operating Income
-$1.50 mln
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)